StreetInsider.com News Articles

Form 8-K STERIS plc For: Oct 11

Tue, 13 Oct 2026 16:30:00 -0400

si-local-file:///var/storage/secattach/20261013/27181518.html

STERIS agrees to acquire surgical safety firm Xodus Medical

Mon, 12 Oct 2026 14:44:12 -0400

STERIS (NYSE: STE) has entered into an agreement to acquire Xodus Medical, a Pittsburgh-area developer and manufacturer of surgical safety products, the companies announced.

Xodus Medical, founded in 1993, produces surgical safety technologies including its Pink Pad patient positioning systems. The company has operated for more than 30 years and serves hospitals worldwide.

STERIS, which reported approximately $6 billion in revenue and employs around 18,000 people globally, said the acquisition would add operating room consumables to its existing product portfolio. Dan Carestio, President and Chief Executive Officer of STERIS, said the business "has demonstrated an ability to grow at double-digit rates with

Xodus Medical Announces Agreement to Be Acquired by STERIS (NYSE: STE)

Mon, 12 Oct 2026 14:43:00 -0400

PITTSBURGH, Oct. 12, 2026 /PRNewswire/ -- Xodus Medical, a leading developer and manufacturer of innovative surgical safety solutions, today announced that it has entered into an agreement to be acquired by STERIS, a global provider of products and services that support patient care with an emphasis on infection prevention.

The acquisition represents a significant milestone in Xodus

Xodus Medical Announces Agreement to Be Acquired by STERIS (NYSE: STE)

Mon, 12 Oct 2026 14:43:00 -0400

The acquisition represents a significant milestone in Xodus

STERIS to acquire Xodus Medical for $2.1 billion

Mon, 12 Oct 2026 08:00:24 -0400

STERIS plc (NYSE: STE) has signed a definitive agreement to acquire Xodus Medical, Inc., a Pennsylvania-based specialty surgical products company, for $2.1 billion, according to a company statement.

STERIS anticipates cash tax benefits with a net present value of approximately $300 million, bringing the effective net purchase price to approximately $1.8 billion. The agreement also includes potential earnout consideration of up to $150 million, contingent on Xodus Medical meeting specified performance targets in calendar year 2028.

Xodus Medical, founded in 1993 and headquartered near Pittsburgh, develops and manufactures surgical safety products, including its Pink Pad patient positioning systems. The company's calendar 2026

STERIS Expands Healthcare Consumables Offering with Definitive Agreement to Acquire Xodus Medical, a Specialty Surgical Products Business Focused on Patient and OR Staff Safety

Mon, 12 Oct 2026 08:00:00 -0400

Consumable product portfolio a natural extension for STERIS’s Healthcare Customers
Compelling financial benefits: expected to be accretive to top-line growth, margins and adjusted earnings
Anticipated to close by December 31, 2026

DUBLIN, IRELAND, Oct. 12, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced that STERIS Corporation, a wholly owned subsidiary of the Company, has signed a definitive agreement to acquire Xodus Medical, Inc., a specialty surgical products business based in Pennsylvania, and certain related affiliates (“Xodus Medical”), for $2.1 billion at closing. STERIS anticipates

STERIS Expands Healthcare Consumables Offering with Definitive Agreement to Acquire Xodus Medical, a Specialty Surgical Products Business Focused on Patient and OR Staff Safety

Mon, 12 Oct 2026 08:00:00 -0400

Consumable product portfolio a natural extension for STERIS’s Healthcare Customers
Compelling financial benefits: expected to be accretive to top-line growth, margins and adjusted earnings
Anticipated to close by December 31, 2026

Form 4 STERIS plc For: Oct 01 Filed by: Burton Karen L

Mon, 05 Oct 2026 16:10:00 -0400

si-local-file:///var/storage/secattach/20261005/27148872.html

STERIS to Present at the Morgan Stanley Healthcare Conference

Tue, 01 Sep 2026 16:30:00 -0400

Dublin, Ireland, Sept. 01, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will participate in the Morgan Stanley Healthcare Conference in New York City on Tuesday, September 15, 2026. Dan Carestio, President and CEO of STERIS will present at 1:05 p.m. Eastern Time.

A simultaneous webcast and replay of the Company’s presentation will be available on STERIS’s investor relations website at www.steris-ir.com.

About STERIS
STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention. WE HELP

STERIS to Present at the Morgan Stanley Healthcare Conference

Tue, 01 Sep 2026 16:30:00 -0400

A simultaneous webcast and replay of the Company’s presentation will be available on STERIS’s investor relations website at www.steris-ir.com.

About STERIS
STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention. WE HELP

Form 144 STERIS plc Filed by: Breeden Richard C

Tue, 18 Aug 2026 17:26:00 -0400

si-local-file:///var/storage/secattach/20260818/26945548.html

Form 144 STERIS plc Filed by: Breeden Richard C

Tue, 18 Aug 2026 17:26:00 -0400

si-local-file:///var/storage/secattach/20260818/26945548.html

Form 4 STERIS plc For: Aug 10 Filed by: Sohi Mohsen

Wed, 12 Aug 2026 16:34:00 -0400

si-local-file:///var/storage/secattach/20260812/26913566.html

Form 4 STERIS plc For: Aug 10 Filed by: Sohi Mohsen

Wed, 12 Aug 2026 16:34:00 -0400

si-local-file:///var/storage/secattach/20260812/26913566.html

Form 4 STERIS plc For: Aug 10 Filed by: Martin Paul Edward